Avoro Capital Advisors
North America, New York, United States, New York
Description
Avoro Capital Advisors is a global life sciences investment firm.
Investor Profile
Avoro Capital Advisors has made 19 investments, with 3 in the past 12 months and 21% as lead.
Stage Focus
- Post Ipo Equity (47%)
- Series C (21%)
- Series B (21%)
- Series D (5%)
- Series A (5%)
Country Focus
- United States (79%)
- Ireland (5%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
- Switzerland (5%)
- Denmark (5%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Biopharma
- Life Science
- Medical
- Oncology
- Pharmaceutical
- Alternative Medicine
- Precision Medicine
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
